Purchase Order 75N95D22P00132

This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $11,593.80 award is for the delivery of HU PB MONOCYTES, CRYO, 4X10E7 (2 VIALS), with a completion date of July 15, 2024. The contract has no set-aside designation. Stemcell Technologies Inc. is a supplier of...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Peprotech Inc., a biotechnology company that develops and manufactures cytokine products. The $3,560.00 Firm Fixed Price Purchase Order is for the delivery of recombinant human M-CSF 250 ug, a biological reagent material used in research. Peprotech Inc. has received several prior awards from the Department of Health and Human Services (HHS), National Institutes of Health (NIH), and other...

This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies. The $10,820 contract is for the provision of human neutrophil isolation kits and related reagents and supplies to support an ongoing sepsis study being conducted by the NHLBI. This contract does not have a small business...

This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Amgen USA Inc., a subsidiary of Amgen Inc., to provide a colony stimulating factor (G-CSF or GM-CSF) as a medical countermeasure for mitigating neutropenia arising from exposure to ionizing radiation. The contract is a $154,445,489.12 firm fixed price delivery order under the HHS Colony Stimulating Factor 2013-2018 indefinite delivery contract. The award...

The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price Purchase Order contract worth $94,003.45 to Charles River Laboratories Cell Solutions, Inc. for the provision of human primary CD34+ hematopoietic stem and progenitor cells. This contract supports the FDA's Center for Biologics Evaluation and Research (CBER), Division of Cell and Gene Therapy (DCGT) in conducting critical path research to develop and promote technology for the regulation of cellular and genetic...

The Department of Health and Human Services' National Institutes of Health awarded a $14,907.00 firm fixed-price purchase order to Stemcell Technologies Inc., a Canadian-owned for-profit company, for the delivery of CD10 human isolation kits. The work is to be performed in Seattle, Washington, with a completion date of August 31, 2020. This contract was not set aside for any socioeconomic category. Stemcell Technologies Inc. is an established supplier of specialized biological materials, lab...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,622.50 firm fixed price purchase order to Stemcell Technologies Inc. for cell culture medium under catalog number 2201103. Stemcell Technologies, whose parent company is also Stemcell Technologies, will deliver the requested products from its location in Kent, Washington by January 31, 2024 to support the NIH/NIAID's research efforts. No subcontractors or...

This is a federal contract award made by the Defense Health Agency to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in the United States. The contract, valued at $35,811.99, is for the delivery of the EASYSEP DIRECT HU TOTAL LYMPH ISO KIT, a cell separation product used in biomedical research. The contract is a firm fixed-price purchase order and was not set aside for small businesses. Stemcell Technologies Inc. is a subsidiary of the Canadian...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of the "EasySep Negative Human NK, 1 mL" product, which is a cell separation system used in stem cell research, immunology, and infectious...